selegiline has been researched along with 2-(3,4-dimethoxyphenyl)-3-fluoroallylamine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azam, M; Baquer, NZ; Jain, S | 1 |
| Fozard, JR; Palfreyman, MG; Robin, M; Zreika, M | 2 |
| Heikkila, RE; Kindt, MV | 1 |
| Jarrott, B; Vajda, FJ | 1 |
| Cabbat, FS; Duvoisin, RC; Heikkila, RE; Manzino, L | 1 |
1 review(s) available for selegiline and 2-(3,4-dimethoxyphenyl)-3-fluoroallylamine
| Article | Year |
|---|---|
The current status of monoamine oxidase and its inhibitors.
Topics: Allylamine; Benzamides; Clinical Trials as Topic; Humans; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Selegiline | 1987 |
1 trial(s) available for selegiline and 2-(3,4-dimethoxyphenyl)-3-fluoroallylamine
| Article | Year |
|---|---|
The current status of monoamine oxidase and its inhibitors.
Topics: Allylamine; Benzamides; Clinical Trials as Topic; Humans; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Selegiline | 1987 |
5 other study(ies) available for selegiline and 2-(3,4-dimethoxyphenyl)-3-fluoroallylamine
| Article | Year |
|---|---|
Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
Topics: Allylamine; Brain Chemistry; Clorgyline; Cytosol; Dose-Response Relationship, Drug; Mitochondria; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Polyethylene Glycols; Receptors, Drug; Selegiline | 1990 |
Selective inhibition of monoamine oxidase type B by MDL 72145 increases the central effects of L-dopa without modifying its cardiovascular effects.
Topics: Allylamine; Amines; Animals; Blood Pressure; Brain; Decerebrate State; Dose-Response Relationship, Drug; Drug Synergism; Heart Rate; Hydroxydopamines; Levodopa; Male; Monoamine Oxidase Inhibitors; Oxidopamine; Rats; Rats, Inbred Strains; Selegiline | 1986 |
Prevention of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic toxicity in mice by MDL 72145, a selective inhibitor of MAO-B.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Allylamine; Amines; Animals; Brain; Clorgyline; Dopamine; Male; Mice; Mitochondria; Monoamine Oxidase Inhibitors; Pyridines; Selegiline | 1986 |
Studies on the oxidation of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase B.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Allylamine; Animals; Benzylamines; Brain; Clorgyline; Indans; Kinetics; Mice; Mice, Inbred C57BL; Mitochondria; Monoamine Oxidase; Oxidation-Reduction; Pyridines; Selegiline; Tryptamines | 1985 |
The functional consequences of inhibition of monoamine oxidase type B: comparison of the pharmacological properties of L-deprenyl and MDL 72145.
Topics: Allylamine; Amines; Animals; Body Temperature; Brain; Electric Stimulation; Hemodynamics; Hydroxydopamines; Male; Mice; Monoamine Oxidase Inhibitors; Motor Activity; Norepinephrine; Oxidopamine; Phenethylamines; Rats; Rats, Inbred Strains; Reserpine; Selegiline; Spinal Cord; Sympathectomy, Chemical; Sympathetic Nervous System; Tyramine | 1985 |